Multi-omics exploration of biomolecular corona in nanomedicine therapeutics and diagnostics

References

• 1. Dawson KA, Yan Y. Current understanding of biological identity at the nanoscale and future prospects. Nat. Nanotechnol. 2021;16(3):229–242.
  Medline CASGoogle Scholar
• 2. Monopoli MP, Åberg C, Salvati A et al. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 2012;7(12):779–786.
  Medline CASGoogle Scholar
• 3. Mahmoudi M, Landry MP, Moore A et al. The protein corona from nanomedicine to environmental science. Nat. Rev. Mater. 2023;8(7):422–438.
  Google Scholar
• 4. Salvati A, Pitek AS, Monopoli MP et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 2013;8(2):137–143.
  Medline CASGoogle Scholar
• 5. Hadjidemetriou M, Mahmoudi M, Kostarelos K. In vivo biomolecule corona and the transformation of a foe into an ally for nanomedicine. Nat. Rev. Mater. 2024;9:219–222. Available from: https://www.nature.com/articles/s41578-024-00658-1
  Google Scholar
• 6. Mertins P, Tang LC, Krug K et al. Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry. Nat. Protocols 2018;13(7):1632–1661.
  Medline CASGoogle Scholar
• 7. Hajipour MJ, Laurent S, Aghaie A et al. Personalized protein coronas: a “key” factor at the nanobiointerface. Biomat. Sci. 2014;2(9):1210–1221.
  CASGoogle Scholar
• 8. Hajipour MJ, Raheb J, Akhavan O et al. Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide. Nanoscale 2015;7(19):8978–8994.
  Medline CASGoogle Scholar
• 9. Caracciolo G, Safavi-Sohi R, Malekzadeh R et al. Disease-specific protein corona sensor arrays may have disease detection capacity [10.1039/C9NH00097F]. Nanosc. Horiz. 2019;4(5):1063–1076.
  CASGoogle Scholar
• 10. Blume JE, Manning WC, Troiano G et al. Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona. Nat. Commun. 2020;11(1):3662.
  Medline CASGoogle Scholar
• 11. Hadjidemetriou M, Al-Ahmady Z, Buggio M et al. A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona. Biomaterials 2019;188:118–129.
  Medline CASGoogle Scholar
• 12. Raesch SS, Tenzer S, Storck W et al. Proteomic and lipidomic analysis of nanoparticle corona upon contact with lung surfactant reveals differences in protein, but not lipid composition. ACS Nano 2015;9(12):11872–11885.
  Medline CASGoogle Scholar
• 13. Papafilippou L, Nicolaou A, Kendall AC et al. The lipidomic profile of the nanoparticle-biomolecule corona reflects the diversity of plasma lipids. Nanoscale 2023;15(26):11038–11051.
  Medline CASGoogle Scholar
• 14. Chetwynd AJ, Zhang W, Thorn JA et al. The nanomaterial metabolite corona determined using a quantitative metabolomics approach: a pilot study. Small 2020;16(21):2000295.
  CASGoogle Scholar
• 15. Grintzalis K, Lawson TN, Nasser F et al. Metabolomic method to detect a metabolite corona on amino-functionalized polystyrene nanoparticles. Nanotoxicology 2019;13(6):783–794.
  Medline CASGoogle Scholar
• 16. Tang H, Zhang Y, Yang T et al. Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona. Nat. Nanotechnol. 2023;18(9):1067–1077.
  Medline CASGoogle Scholar
• 17. Ashkarran AA, Gharibi H, Voke E et al. Measurements of heterogeneity in proteomics analysis of the nanoparticle protein corona across core facilities. Nat. Commun. 2022;13(1):6610.
  Medline CASGoogle Scholar
• 18. Gharibi H, Ashkarran AA, Jafari M et al. A uniform data processing pipeline enables harmonized nanoparticle protein corona analysis across proteomics core facilities. Nat. Commun. 2024;15(1):342.
  Medline CASGoogle Scholar
• 19. Ashkarran AA, Gharibi H, Modaresi SM et al. Deep plasma proteome profiling by modulating single nanoparticle protein corona with small molecules. bioRxiv 2024;2024.03.06.582595.
  MedlineGoogle Scholar
• 20. Smith LM, Kelleher NL, Linial M et al. Proteoform: a single term describing protein complexity. Nat. Meth. 2013;10(3):186–187.
  Medline CASGoogle Scholar
• 21. Sadeghi S, Ashkarran A, Mahmoudi M et al. Mass spectrometry-based top-down proteomics in nanomedicine: proteoform-specific measurement of protein corona. bioRxiv 2024. Available from: www.biorxiv.org/content/10.1101/2024.03.22.586273v1
  MedlineGoogle Scholar